Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gruev

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Vutreshni Bolesti|January 1, 1985
[Microbial spectrum in chronic pyelonephritis and the drug sensitivity of the microorganisms]I Gruev, M Lobutova, B Markova, et al.
Vutreshni Bolesti|January 1, 1985
[Comparative clinical x-ray, radioisotope nephrographic and ultrasonic studies of chronic pyelonephritis patients]I Gruev, R Robeva, Kh Mlŭchkov, et al.
Vutreshni Bolesti|January 1, 1990
[Endoperoxides and the immunological indices of patients with chronic pyelonephritis]M Kiroĭcheva, D Popova, I Gruev, et al.
Vutreshni Bolesti|January 1, 1983
[Hyperprolactinemia in chronic kidney failure patients]S Milanov, N Belovezhdov, I Gruev, et al.
Terapevticheskii Arkhiv|January 1, 1975
[Hyperlipoproteinemia in patients with primary and secondary glomerular nephropathies]S Razboĭnikov, P Shipkova, I Tishkov, et al.
Vutreshni Bolesti|January 1, 1980
[Fulminant mycotic sepsis in a patient undergoing immunosuppressive treatment for the acute crisis of kidney transplant rejection]G Stefanov, D Doĭchinov, I Gruev, et al.
Vutreshni Bolesti|January 1, 1980
[Severe posttransplant lung syndrome and an acute transplanted kidney rejected crisis successfully controlled]G Stefanov, I Gruev, D Mushmov, et al.
Vutreshni Bolesti|January 1, 1983
[Pulmonary thromboembolism as a complication of latent glomerulonephritis with nephrotic syndrome]N Belovezhdov, I Gruev, I Ivanov, et al.
Vutreshni Bolesti|January 1, 1989
[Changes in the level of urinary secretory immunoglobulin A in patients with recurrent pyelonephritis]I Gruev, M Kiroĭcheva, K Nikolov, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1986
Liver insufficiency as a factor modifying the pharmacokinetic characteristic of the preparation nabumetoneA Maleev, V Vlahov, I Gruev, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Vutreshni Bolesti|January 1, 1985
[Microbial spectrum in chronic pyelonephritis and the drug sensitivity of the microorganisms]I Gruev, M Lobutova, B Markova, et al.
Vutreshni Bolesti|January 1, 1985
[Comparative clinical x-ray, radioisotope nephrographic and ultrasonic studies of chronic pyelonephritis patients]I Gruev, R Robeva, Kh Mlŭchkov, et al.
Vutreshni Bolesti|January 1, 1990
[Endoperoxides and the immunological indices of patients with chronic pyelonephritis]M Kiroĭcheva, D Popova, I Gruev, et al.
Vutreshni Bolesti|January 1, 1983
[Hyperprolactinemia in chronic kidney failure patients]S Milanov, N Belovezhdov, I Gruev, et al.
Terapevticheskii Arkhiv|January 1, 1975
[Hyperlipoproteinemia in patients with primary and secondary glomerular nephropathies]S Razboĭnikov, P Shipkova, I Tishkov, et al.
Vutreshni Bolesti|January 1, 1980
[Fulminant mycotic sepsis in a patient undergoing immunosuppressive treatment for the acute crisis of kidney transplant rejection]G Stefanov, D Doĭchinov, I Gruev, et al.
Vutreshni Bolesti|January 1, 1980
[Severe posttransplant lung syndrome and an acute transplanted kidney rejected crisis successfully controlled]G Stefanov, I Gruev, D Mushmov, et al.
Vutreshni Bolesti|January 1, 1983
[Pulmonary thromboembolism as a complication of latent glomerulonephritis with nephrotic syndrome]N Belovezhdov, I Gruev, I Ivanov, et al.
Vutreshni Bolesti|January 1, 1989
[Changes in the level of urinary secretory immunoglobulin A in patients with recurrent pyelonephritis]I Gruev, M Kiroĭcheva, K Nikolov, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1986
Liver insufficiency as a factor modifying the pharmacokinetic characteristic of the preparation nabumetoneA Maleev, V Vlahov, I Gruev, et al.
Pageof 5